Patricia Fuqua Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 200 Elizabeth St, Charleston, WV 25311 Phone: 304-348-7740 Fax: 304-348-6671 |
Jennifer Lynn Dennison, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 658 Piccadilly St, Charleston, WV 25302 Phone: 304-617-2924 Fax: 304-617-2924 |
Norma Ulery Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 200 Elizabeth St, Charleston, WV 25311 Phone: 304-348-7740 Fax: 304-348-6671 |
Luanne Mcclung Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 200 Elizabeth St, Charleston, WV 25311 Phone: 304-348-7740 Fax: 304-348-6671 |
Julie Perry Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 200 Elizabeth St, Charleston, WV 25311 Phone: 304-348-7740 Fax: 304-348-6671 |
Shari Nutter Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 200 Elizabeth St, Charleston, WV 25311 Phone: 304-348-7740 |
Denia Debord Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 200 Elizabeth St, Charleston, WV 25311 Phone: 304-766-7655 Fax: 304-755-2824 |
Janice Carroll Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 200 Elizabeth St, Charleston, WV 25311 Phone: 304-766-7655 Fax: 304-755-2824 |
Mrs. Jenna Marie Randall, M.S.CCC/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 300 Baker Ln, Charleston, WV 25302 Phone: 304-345-0867 Fax: 304-342-2587 |
Lisa Bibbee Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 200 Elizabeth St, Charleston, WV 25311 Phone: 304-766-7655 Fax: 304-755-2824 |
Jennifer Asbury Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 200 Elizabeth St, Charleston, WV 25311 Phone: 304-766-7655 Fax: 304-755-2824 |
Holly Humphreys Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 200 Elizabeth St, Charleston, WV 25311 Phone: 304-348-7740 |
Mrs. Christina Renee Painter, M.A. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 113 Lakeview Dr, Charleston, WV 25313 Phone: 304-342-9515 |
Kelli Ross Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 200 Elizabeth St, Charleston, WV 25311 Phone: 304-348-7740 Fax: 304-348-6671 |
Elizabeth Simmons Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 200 Elizabeth St, Charleston, WV 25311 Phone: 304-348-7740 Fax: 304-348-6671 |
Mrs. Jodi Watson Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 200 Elizabeth St, Charleston, WV 25311 Phone: 304-348-7740 |
Crystal Griffith Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1015 Oakhurst Dr, Charleston, WV 25314 Phone: 941-312-3232 |
Colleen L. Herald, MA, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1015 Oakhurst Dr, Charleston, WV 25314 Phone: 304-345-8101 Fax: 304-345-7386 |
Amber Dawn Settles, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1313 Quarrier St Ste A, Charleston, WV 25301 Phone: 304-342-7852 Fax: 304-342-2970 |
Marea Akers, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 200 Elizabeth St, Charleston, WV 25311 Phone: 304-348-7740 |
News Archive
A Ventura County commission is trying to keep secret the details of a state-ordered investigation into the management and claims procedures of a healthcare plan designed to serve the county's neediest residents. Complaints about alleged late payments and poor management prompted the Department of Health Care Services to request that auditors step in and examine the plan's financial condition and claims practices. Gold Coast Health Plan was launched last year to switch an estimated 110,000 Ventura County Medi-Cal beneficiaries into an HMO-style healthcare plan.
Eli Lilly and Company announced today that the U.S. Food and Drug Administration (FDA) has approved CYRAMZA (ramucirumab) in combination with paclitaxel (a type of chemotherapy) as a treatment for people with advanced or metastatic gastric (stomach) or gastroesophageal junction (GEJ) adenocarcinoma whose cancer has progressed on or after prior fluoropyrimidine- or platinum-containing chemotherapy.
The Case for Quality, a collaboration between FDA, the medical device industry, healthcare providers and quality experts, released its first report on the feasibility and effectiveness of using standardized medical device performance data and analytic techniques to help hospitals better compare and evaluate product quality.
Antigenics Inc. reported today its results for the quarter ended September 30, 2010. The company incurred a net loss attributable to common stockholders of $5.9 million, or $0.06 per share, basic and diluted, for the third quarter of 2010, compared with a net loss attributable to common stockholders of $10.8 million, or $0.13 per share, basic and diluted, in the third quarter of 2009.
› Verified 8 days ago